Press Releases

Westbury, NY - November 7, 2017 - BioIVT, a leading provider of biospecimens and related services, today announced that it will be presenting and exhibiting at the American Association of Pharmaceutical Scientists (AAPS) Annual Meeting. This conference will be held from Nov. 12-15 at the San Diego Convention Center in San Diego, CA. “BioIVT is proud to support AAPS, share our knowledge and experience, and help to support the next generation of pharmaceutical scientists. High content immunohistochemistry (IHC) is an exciting and rapidly-evolving field, and at BioIVT we are expanding our expertise and services to ensure...

Press Releases

Westbury, NY - October 24, 2017 - BioIVT, a leading provider of biospecimens and related services, today announced that it is sponsoring the Powering Precision Health Summit (PPHS) 2017. This conference will bring together leaders in biomarker research and translational medicine to present the latest advances in their disciplines. It will be held from Oct. 24-25 at the Charles Hotel in Cambridge, MA. “We believe ‘precision health’ – when we concentrate on developing treatments for individuals instead of average populations – can transform the industry’s approach from reactive ‘sick care’ to proactive ‘health care.’ By...

Press Releases

Westbury, NY - September 21, 2017 - BioIVT, a leading provider of biospecimens and related services, today announced that it is increasing its support of the annual North American International Society for the Study of Xenobiotics (ISSX) Meeting. BioIVT will be sponsoring two symposia, giving several presentations, and exhibiting at this year’s conference. This event will be held from Sept. 24-28 at the Rhode Island Convention Center in Providence, RI. “ISSX North America has always been an important conference for BioIVT, but after our acquisition of Qualyst Transporter Solutions earlier this month, our focus on this...

Press Releases

Westbury, NY - September 7, 2017 - BioIVT, a leading provider of biospecimens and related services, today announced that it has acquired Qualyst Transporter Solutions, LLC. Qualyst provides in vitro hepatic models and services that predict the effect of drugs and other compounds on the human liver in the pharmaceutical, chemical, consumer products, and cosmetics industries. Qualyst uses a unique cell-based testing approach to predict compound clearance, drug-drug interactions, and toxicity in the human liver. In fact, it established the industry standard for hepatocytes; its Transporter Certified™ hepatocyte program...

Press Releases

Westbury, NY - August 10, 2017 - BioreclamationIVT, a leading provider of biospecimens and related services, today announced that it has acquired Asterand Bioscience™, a global provider of high quality, well-characterized human tissue and research solutions with a focus on the oncology market. Asterand Bioscience advances drug research by accelerating target identification and biomarker validation, and improving drug candidate selection to increase the likelihood of clinical success. “We are delighted that Asterand Bioscience’s talented staff is joining BioreclamationIVT. This is a great fit between two complementary...

Press Releases

Pages